GPX4 and lymphoma: Collectively, these results demonstrate that DLBCL cells, regardless of subtype, exhibit profound sensitivity to ferroptosis induction via small molecule GPX4 inhibition, and that this vulnerability is specific to malignant B-cells, supporting ferroptosis as a selective and mechanistically distinct strategy for therapeutic intervention in aggressive lymphomas.